Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Mitotane

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   



calcium reabsorption1 - triggering1 - nephrotic syndrome4 - infantile polycystic kidneys1 - androgen-independent prostate cancer1 - muscle mass1 - kidney injury6 - pyuria1 - radiographic imaging1 - kidney blood flow1 - pancreatic cancer2 - autosomal dominant polycystic kidney disease1 - bicycling1 - overactive1 - retinopathy1 - myelomatosis1 - sex after prostate removal surgery1 - pharmaceutical science1 - estradiol deficiency1 - radical treatment1 - prostate disorders1 - prostate cancer treatments1 - metabolic syndrome1 - arteriovenous fistula4 - autoimmune disease2 - focal glomerulosclerosis2 - obstructive pyelonephritis1 - health benefits1 - cisplatin1 - heart attack2 -